Lastly, we investigated the effects of demethylation on PD-L1 expression in vitro and correlated expression of PD-L1 with NY-ESO-1 expression and methylation in patients with stage 3 NSCLC. The gene discussed is CTAG1B; the disease is non-small cell lung carcinoma.